VBI Vaccines Inc.
VBIV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $15,196 | $14,052 | $14,101 | $28,322 |
| - Cash | $12,595 | $23,685 | $35,454 | $20,840 |
| + Debt | $50,712 | $53,040 | $50,299 | $52,554 |
| Enterprise Value | $53,313 | $43,407 | $28,946 | $60,036 |
| Revenue | $1,214 | $853 | $6,624 | $720 |
| % Growth | 42.3% | -87.1% | 820% | – |
| Gross Profit | -$1,510 | -$2,564 | $4,099 | -$2,763 |
| % Margin | -124.4% | -300.6% | 61.9% | -383.8% |
| EBITDA | -$15,393 | $2,528 | -$17,888 | -$36,972 |
| % Margin | -1,268% | 296.4% | -270% | -5,135% |
| Net Income | -$17,900 | -$13 | -$20,444 | -$44,628 |
| % Margin | -1,474.5% | -1.5% | -308.6% | -6,198.3% |
| EPS Diluted | -0.73 | -0.001 | -0.97 | -5.18 |
| % Growth | -145,900% | 99.9% | 81.3% | – |
| Operating Cash Flow | -$11,770 | -$11,301 | -$7,960 | -$19,210 |
| Capital Expenditures | -$151 | -$159 | -$113 | -$50 |
| Free Cash Flow | -$11,921 | -$11,460 | -$8,073 | -$19,260 |